Cargando…
Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery
[Image: see text] Drug discovery is a rigorous process that requires billion dollars of investments and decades of research to bring a molecule “from bench to a bedside”. While virtual docking can significantly accelerate the process of drug discovery, it ultimately lags the current rate of expansio...
Autores principales: | Gentile, Francesco, Agrawal, Vibudh, Hsing, Michael, Ton, Anh-Tien, Ban, Fuqiang, Norinder, Ulf, Gleave, Martin E., Cherkasov, Artem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318080/ https://www.ncbi.nlm.nih.gov/pubmed/32607441 http://dx.doi.org/10.1021/acscentsci.0c00229 |
Ejemplares similares
-
Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus Deep Docking of 40 billion small molecules
por: Gentile, Francesco, et al.
Publicado: (2021) -
Computer-Aided Discovery of Small Molecule Inhibitors of Thymocyte Selection-Associated High Mobility Group Box Protein (TOX) as Potential Therapeutics for Cutaneous T-Cell Lymphomas
por: Agrawal, Vibudh, et al.
Publicado: (2019) -
Targeting SARS-CoV-2 papain-like protease in the postvaccine era
por: Ton, Anh-Tien, et al.
Publicado: (2022) -
Dual-Inhibitors of N-Myc and AURKA as Potential Therapy for Neuroendocrine Prostate Cancer
por: Ton, Anh-Tien, et al.
Publicado: (2020) -
Deep Modeling of Regulating Effects of Small Molecules on Longevity-Associated Genes
por: You, Jiaying, et al.
Publicado: (2021)